VIVOTIF is indicated for active oral immunisation against typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), in adults and children aged five years and older.
This vaccine should be used in accordance with official recommendations.
VIVOTIF protects against Salmonella Typhi by mimicking the response to natural infection and stimulating local, cellular and systemic/humoral immunity 2-5
The protective efficacy of VIVOTIF was demonstrated in several large-scale field trials involving more than 500,000 subjects2
VIVOTIF is generally well tolerated with a low incidence of adverse events.
1 capsule taken on Days 1, 3, and 5 may provide up to 3 years of protection against typhoid fever. Complete vaccination is comprised of the ingestion of three capsules. Optimal immune response may not be achieved unless the entire vaccination schedule is completed.
Revaccination is recommended at three years following the most recent vaccination for all individuals.
In the case of travel from a non-endemic area to an area where typhoid is endemic, Green Book recommends a booster consisting of the 3 doses of VIVOTIF be administered every 3 years.6
VIVOTIF is supplied in a single foil blister containing 3 doses of vaccine in a single package.
Storage and Handling
For medical enquiries, please contact Medical Information at 0800 088 5449.
Please find downloadable PDFs of supporting material that may be helpful to your practice.
Please fill out this form and send enquiry to place your order of VIVOTIF.
* These fields are required
Free text message
reminders to help patients
stay on course with VIVOTIF.
Please click the box to confirm that you
are a registered healthcare professional.
Welcome to the new EmergentTravelHealth.com for the UK!
This website was previously PaxVax.co.uk/home – we’ve updated our look and added even more resources for you to explore.